Prevention of the development of melphalan resistance in vitro by selenite

Paula B. Caffrey, Ming Zhu, Gerald D. Frenkel

Research output: Contribution to journalArticle

10 Scopus citations


Exposure of A2780 human ovarian tumor cells to a low concentration of melphalan in vitro for 7 d results in the development of melphalan resistance, which is dependent on elevated cellular levels of glutathione and glutathione S-transferase. The inclusion of selenite (at concentrations as low as 0.2 μM) during the exposure to melphalan completely prevented the development of resistance. Selenite did not prevent the melphalan-induced increase in glutathione, but it did prevent the increase in the activity of glutathione S-transferase. It also prevented the increase in the expression of the glutathione S-transferase gene, suggesting that this may be the mechanism by which it prevents the development of melphalan resistance. The results of this in vitro study suggest that selenite may prove to be useful in preventing the development of drug resistance in vivo.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalBiological Trace Element Research
Issue number3
StatePublished - Jan 1 1998

All Science Journal Classification (ASJC) codes

  • Biochemistry, medical
  • Biochemistry
  • Clinical Biochemistry
  • Inorganic Chemistry
  • Endocrinology, Diabetes and Metabolism


  • Drug resistance
  • Glutathione, glutathione S-transferase
  • Ovarian tumor cells
  • Selenite

Fingerprint Dive into the research topics of 'Prevention of the development of melphalan resistance in vitro by selenite'. Together they form a unique fingerprint.

  • Cite this